Jun 19, 2026
15 MIN READ

Ozempic® and Metformin: Navigating Your Treatment – Can I Stop Metformin If I Take Ozempic?

Many patients wonder if semaglutide can replace metformin for diabetes management. The answer depends on your blood sugar control, kidney function, and individual health goals. PlexusDx explains what evidence shows and how to work with your doctor.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 19, 2026
15 MIN READ

ozempic® and metformin: navigating your treatment – can i stop metformin if i ta — PlexusDx GLP-1 education

Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide (brand name Ozempic®) and metformin are both powerful diabetes medications, but they work through different mechanisms—one stimulates insulin release and slows digestion, while the other reduces liver glucose production. If you take metformin and are considering semaglutide therapy, you may wonder whether you can stop one medication and rely solely on the other. The short answer is: it depends, and any change must be made under medical supervision.

How Semaglutide and Metformin Work Differently in Your Body

Metformin is a first-line diabetes medication that decreases the amount of glucose your liver produces and improves how your cells respond to insulin. It has been used safely for decades and carries a low risk of causing low blood sugar on its own. Semaglutide belongs to a class called GLP-1 receptor agonists, which mimic a natural hormone in your body that tells your pancreas to release insulin when blood sugar rises, slows stomach emptying, and signals fullness to your brain.

Because these medications operate through distinct pathways, combining them often produces better blood sugar control than either drug alone. Research shows that adding a GLP-1 receptor agonist to metformin therapy typically lowers hemoglobin A1C (a three-month blood sugar average) by 1.5 to 2 percentage points, compared to smaller reductions with metformin monotherapy. This synergistic effect is why many doctors prescribe both drugs together rather than as alternatives.

Can You Stop Metformin When Starting Semaglutide?

Stopping metformin should only happen after consulting your healthcare provider and carefully monitoring your blood glucose levels. Some patients achieve adequate diabetes control on semaglutide alone, especially if their metformin dose was modest or if they respond exceptionally well to GLP-1 therapy. However, discontinuing metformin without medical guidance risks losing the glucose-lowering benefits it provides through liver function, which semaglutide does not directly target in the same way.

Clinical trials demonstrate that patients who switch from metformin-plus-placebo to metformin-plus-semaglutide see superior outcomes compared to those on semaglutide alone. If your doctor determines that semaglutide achieves your blood sugar targets, a gradual reduction in metformin (not an abrupt stop) may be appropriate, with regular A1C testing to ensure control remains stable. The decision should account for your kidney function, diabetes duration, current A1C level, and any other health conditions you have.

Safety Considerations: Drug Interactions and Kidney Function

Metformin requires careful dosing if you have reduced kidney function because the drug is eliminated by the kidneys and can accumulate to dangerous levels. Semaglutide does not pose the same kidney-dependent dosing concern, though it may need adjustment in severe renal impairment. Both drugs together are safe in most patients with mild-to-moderate kidney disease, but your doctor must assess your specific glomerular filtration rate (eGFR) before making any medication changes.

Semaglutide can slow stomach emptying, which theoretically could affect metformin absorption, but clinical evidence of a clinically significant interaction is limited. More importantly, both drugs carry the risk of gastrointestinal side effects—nausea, vomiting, diarrhea—and combining them may increase these symptoms, especially at higher doses. If tolerability becomes an issue, your healthcare team may reduce or discontinue one medication rather than both, prioritizing the agent that offers the most benefit for your specific health profile.

Why Personalized Genetic Testing Matters for GLP-1 Therapy

Not all patients respond equally to semaglutide or other GLP-1 receptor agonists, and genetic variations influence how your body processes these medications and whether you're a candidate for GLP-1 monotherapy. PlexusDx offers the Precision Peptide Genetic Test, which identifies variations in genes controlling GLP-1 receptor signaling, GIPR pathways, and metabolic genes like FTO and MC4R. These insights help determine whether semaglutide alone is likely to achieve your diabetes and weight loss goals, or whether combination therapy with metformin remains optimal.

The test maps 14 peptide-related pathways and 150+ genetic insights without requiring insurance, making it an accessible tool for patients considering medication changes. Understanding your genetic predispositions to GLP-1 response allows you and your doctor to make informed decisions about whether discontinuing metformin is realistic, or whether dual therapy remains the safer, more effective approach. PlexusDx compounded semaglutide injections start at $149 per month, with the genetic test available as a $99 add-on after your first month of treatment, ensuring you receive truly personalized guidance.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is it safe to take semaglutide and metformin together?

Yes, combining semaglutide and metformin is safe and often more effective than either drug alone. Both medications work through different mechanisms to lower blood sugar, and clinical trials support their combined use. However, you may experience increased gastrointestinal side effects, so your doctor should monitor your tolerance and adjust doses if needed.

What clinical evidence supports stopping metformin for semaglutide?

No large trial shows that semaglutide monotherapy definitively replaces metformin for all patients. Some individuals achieve adequate blood sugar control on semaglutide alone, particularly if they respond strongly or have mild diabetes. Your healthcare provider should base any decision to discontinue metformin on your personal A1C response, kidney function, and renal monitoring over at least 3 months on the new therapy.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx compounded semaglutide injections start at $149 per month, with no membership fees or insurance required. The medication comes from licensed 503A compounding pharmacies and is HSA/FSA eligible. PlexusDx serves all 50 states, making personalized GLP-1 therapy accessible regardless of your insurance status.

What side effects should I expect if I take both medications?

Common side effects of semaglutide include nausea, vomiting, constipation, and diarrhea, which may be compounded by metformin's gastrointestinal effects. Most side effects diminish within weeks as your body adjusts, especially if your doctor starts at a low dose and increases gradually. Serious side effects are rare, but report severe abdominal pain, persistent vomiting, or signs of pancreatitis to your doctor immediately.

How can PlexusDx genetic testing help me decide about my medications?

The PlexusDx Precision Peptide Genetic Test identifies variations in your GLP-1 receptor, GIPR, FTO, and MC4R genes—all involved in how you respond to semaglutide therapy. This $99 add-on test (after your first month) reveals whether your genetic profile predicts strong GLP-1 response, potentially making semaglutide monotherapy viable, or whether combination therapy with metformin remains your best option for sustained diabetes control.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves